Literature DB >> 6731349

Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading.

H L Evans.   

Abstract

Sixty-nine cases of mucoepidermoid carcinoma with a minimum of five years follow-up are presented. Major salivary glands were involved in 46 cases (44 parotid, two submandibular), and intraoral minor glands in 23. The tumor was considered histologically high grade (20 cases) when 90% or more of its area was made up of tumor cells and 10% or less of intracystic space and low grade (49 cases) when this ratio was lower. The proportion of cell types was not considered in grading: although intermediate, epidermoid, and clear cells usually predominated in high-grade tumors, several such examples contained numerous mucous cells. Grade was highly significant prognostically; all but 2 of the 14 deaths due to tumor and all six instances of distant metastasis occurred in cases with high-grade tumors. High histologic grade also was associated with an increased incidence of local recurrence (particularly recurrence not subsequently controlled) and cervical lymph node metastasis; in the case of recurrence this was due in part to the fact that inadequate surgical margins were more common with high-grade tumors. Tumors measuring less than 2.5 cm were rarely fatal regardless of grade, there being only two such deaths (one high grade, one low grade). Nuclear anisochromia and pleomorphism of more than slight degree, frequent mitoses, and tumor necrosis of more than focal extent were found to be untypical of mucoepidermoid carcinoma regardless of grade; these findings should occasion consideration of other diagnoses such as poorly differentiated adenocarcinoma with a solid growth pattern and adenosquamous carcinoma.

Entities:  

Mesh:

Year:  1984        PMID: 6731349     DOI: 10.1093/ajcp/81.6.696

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  21 in total

Review 1.  Troublesome tumours 2: borderline tumours of salivary glands.

Authors:  J W Eveson
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

2.  Adenosquamous Carcinoma of the Head and Neck: A Case-Control Study with Conventional Squamous Cell Carcinoma.

Authors:  Mitra Mehrad; Kathryn Trinkaus; James S Lewis
Journal:  Head Neck Pathol       Date:  2016-05-12

3.  Expression of Membrane-Bound Mucins and p63 in Distinguishing Mucoepidermoid Carcinoma from Papillary Cystadenoma.

Authors:  Emily A Lanzel; Ali Pourian; Saulo L Sousa Melo; Kim A Brogden; John W Hellstein
Journal:  Head Neck Pathol       Date:  2016-06-09

4.  Mucoepidermoid carcinoma of the oral cavity.

Authors:  B Kolude; J O Lawoyin; E E Akang
Journal:  J Natl Med Assoc       Date:  2001-05       Impact factor: 1.798

5.  Molecular diagnosis in head and neck: what a surgical pathologist must know.

Authors:  Jennifer L Hunt
Journal:  Head Neck Pathol       Date:  2008-02-26

6.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

7.  Prognostic significance of DNA ploidy in mucoepidermoid carcinoma.

Authors:  P Gemryd; P G Lundquist; M Tytor; H B Hellquist; B Nordenskjöld
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

8.  Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression.

Authors:  S I Chiosea; E L Barnes; S Y Lai; A M Egloff; R L Sargent; J L Hunt; R R Seethala
Journal:  Virchows Arch       Date:  2008-02-01       Impact factor: 4.064

9.  Discordance between fine-needle aspiration cytology and histopathology in patients with mucoepidermoid carcinoma of parotid gland.

Authors:  H Iftikhar; M Sohail Awan; M Usman; A Khoja; W Khan
Journal:  Ann R Coll Surg Engl       Date:  2020-03-11       Impact factor: 1.891

Review 10.  [Salivary gland tumors--tumor typing and grading].

Authors:  T Löning; K T Jäkel
Journal:  Pathologe       Date:  2004-02       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.